Invention Grant
US08268618B2 Repressing endogenous CCR5 gene expression in cells using engineered zinc finger proteins
有权
使用工程化锌指蛋白抑制细胞内源性CCR5基因表达
- Patent Title: Repressing endogenous CCR5 gene expression in cells using engineered zinc finger proteins
- Patent Title (中): 使用工程化锌指蛋白抑制细胞内源性CCR5基因表达
-
Application No.: US11505044Application Date: 2006-08-16
-
Publication No.: US08268618B2Publication Date: 2012-09-18
- Inventor: George Norbert Cox, III , Casey Christopher Case , Stephen P. Eisenberg , Eric Edward Jarvis , Sharon Kaye Spratt
- Applicant: George Norbert Cox, III , Casey Christopher Case , Stephen P. Eisenberg , Eric Edward Jarvis , Sharon Kaye Spratt
- Applicant Address: US CA Richmond
- Assignee: Sangamo BioSciences, Inc.
- Current Assignee: Sangamo BioSciences, Inc.
- Current Assignee Address: US CA Richmond
- Agency: Pasternak Patent Law
- Agent Dahna S. Pasternak
- Main IPC: C12N5/00
- IPC: C12N5/00 ; C12N5/02 ; C12Q1/68 ; C07H21/02 ; C07H21/04
Abstract:
The present invention provides methods for modulating expression of endogenous cellular genes using recombinant zinc finger proteins.
Public/Granted literature
- US20060276427A1 Regulation of endogenous gene expression in cells using zinc finger proteins Public/Granted day:2006-12-07
Information query
